News

Medical Products National Manufacturing Priority road map – Now Open

Date posted – 1 March 2021 Closing date – around 1 April 2021 The Australian Government is manufacturing a new future for our nation. Manufacturing is critical to a modern Australian economy—a key part of almost every supply…

Funding for businesses to translate research and ideas into commercial outcomes – Now Open

Date posted – 1 March 2021 Closing date around – 1 April 2021 The Manufacturing Translation Stream provides businesses with funding to support projects that translate high quality research into commercial outcomes and support businesses to scale-up and…

Funding for businesses to integrate their products and services into domestic and global value chains – Now Open

Date posted – 1 March 2021 Closing date – around 1 April 2021 The Manufacturing Integration Stream supports projects that integrate Australian businesses into domestic and international value chains, propelling their goods and services into new markets. It…

Monash University and PureTech Health develop novel technology platform that targets drugs to the lymphatics and lymph nodes

Date posted – 26 February 2021 Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) and PureTech Health (LSE: PRTC, Nasdaq: PRTC) have developed a novel technology platform that directly targets gut lymphatics and has great potential to…

Medical devices reforms: Personalised medical devices

25 February 2021 Please note: While submission of a notification to the TGA is required within two (2) months of initial manufacture/supply of a custom-made medical device, many stakeholders have not been meeting this obligation. If you were supplying…

Grants for Victorian HealthTech Angel Networks

24 February, 2021 In 2020, LaunchVic provided funding to support the establishment of four new Angel Networks to help unlock investment capital for early-stage Victorian Startups. The four new Angel Networks, along with the existing Angel Networks in…

VivaZome and La Trobe University enter new research collaboration to develop exosome therapeutics.

16 February 2021 VivaZome Therapeutics Pty Ltd (“VivaZome”) and La Trobe University today announced that they have entered into a new collaborative research project focussed on developing novel exosome therapeutics. Under the collaborative arrangement, VivaZome scientists will work…

TGA approves first Australian commercial CAR-T manufacturing site – bringing faster access to eligible Australians with life-threatening blood cancers

12 February 2021 • Kymriah® (tisagenlecleucel)[pronounced kim-RY-uh], a chimeric antigen receptor T cell (CAR-T) one-time treatment, will be the first commercially approved CAR-T therapy to be manufactured in Australia • Providing manufacturing capabilities in Australia will help reduce…

New appointments at Biointelect

12 February 2021 Biointelect has made several new appointments to its Sydney and Melbourne-based teams as it experiences strong growth across all its three main consulting workstreams: R&D strategy and planning, biotech commercialisation and strategic market access, health…

First-hand experience sparks Rhinomed to develop high comfort swab

Posted 10 December 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. In April this year, as the world came to grips with the global COVID-19 pandemic, Rhinomed CEO Michael…

Monash University partners with HuiKang Bio-Tech to develop new class of anti-infectives

7 December 2020 Monash University has announced a collaboration with leading protein and peptide experts, HuiKang Bio-Tech, to develop a new class of anti-infectives. The collaboration is being led by Professor Ray Norton from the Monash Institute of…

Stephens Lawyers & Consultants: ACCC Enforcement Proceedings – Unfair Contract Terms

1 December 2020 From Katarina Klaric (Principal & Director) and Peter Divitcos (Lawyer), Stephens Lawyers & Consultants Standard form contracts are being subjected to increased scrutiny for unfair contract terms by regulators. On-line terms and conditions are of…

Home

News & opinion

Member Directory

Events